SomnoMed Limited
(ASX:SOM) announced 30 percent growth in total revenues generated from the sale of SomnoDent devices for the first half of 2015/16.
This compares with sales revenue of $18.05 million the previous year.
The company said non device revenues – including managed dental service fees, cleaning tablets and repair services fees amounted to $3.29 million.
SomnoMed noted excellent performance in US direct sales, alongside solid growth in the European markets and growing acceptance for all new products, contributing to total revenues for the half year to December of $21.3 million.
SomnoMed recorded a net profit of $534 thousand at 30 June 2015.
